Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An announcement from Benchmark Holdings ( (GB:BMK) ) is now available.
Benchmark Holdings plc announced that shareholders approved the sale of its Genetics business to Starfish Bidco AS, a subsidiary of Novo Holdings A/S, at a general meeting. This strategic disposal is subject to receiving necessary merger control and foreign investment clearances, with completion expected in the first quarter of 2025, which will impact Benchmark’s operations by focusing its resources on its remaining business areas.
More about Benchmark Holdings
Benchmark Holdings plc is a leading aquaculture biotechnology company focused on sustainability in the industry. It provides products and solutions in genetics, advanced nutrition, and health to improve yield, growth, and animal health and welfare across major aquaculture species such as salmon, shrimp, sea bass, sea bream, and tilapia globally.
YTD Price Performance: -1.62%
Average Trading Volume: 120,982
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £247.8M
See more insights into BMK stock on TipRanks’ Stock Analysis page.
